Table 1.
Age and sex distribution of populational COVID-19 affection.
| Age groups and sex (% of subgroup) | Population | Confirmed COVID-19 (% of pop.) | Hospitalization (% of cases) | ICU (% of cases) | Mortality (% of cases) | Adverse events (% of cases) |
|---|---|---|---|---|---|---|
| N: 447.979 | N: 965 | N: 234 | N: 33 | N: 38 | N: 124 | |
| 0–14 years | 53.627 | 15 (0.03) | 1 (6.67) | 0 (0.00) | 0 (0.00) | 1 (0.00) |
| Female | 9 | 1 (6.67) | – | – | 1 (6.67) | |
| Male | 6 | 0 (0.00) | – | – | – | |
| 15–64 years | 286.951 | 508 (0.18) | 79 (15.55) | 10 (1.97) | 0 (0.00) | 24 (4.72) |
| Male | 221 | 44 (19.9) | 9 (4.07) | – | 13 (5.88) | |
| Female | 287 | 35 (12.20) | 2 (0.70) | – | 11 (3.83) | |
| >64 years | 107.401 | 442 (0.42) | 154 (34.84) | 23 (5.20) | 38 (8.60) | 99 (22.40) |
| Male | 198 | 93 (46.96) | 15 (7.56) | 30 (15.15) | 69 (34.85) | |
| Female | 244 | 61 (25.42) | 8 (3.33) | 8 (3.33) | 20 (8.20) |
ICU: Intensive care unit. Adverse events (death, ICU admission, invasive mechanical ventilation, bleeding > BARC3, acute renal injury, respiratory insufficiency, myocardial infarction, acute heart failure, pulmonary emboli or stroke). BARC: Bleeding Academy Research Consortium. In the second block of columns the denominator is the total age subgroup population, in the third block of columns, the denominator is the total age and sex subgroup.